Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glucosamine-6-phosphate deaminase 2 pseudogene (ENSG00000271166, also known as LOC100420790) is a non-coding pseudogene closely related to the functional glucosamine-6-phosphate deaminase 2 gene (GNPDA2), which catalyzes the conversion of D-glucosamine-6-phosphate into D-fructose-6-phosphate and ammonium in carbohydrate metabolism[1][2][4][12]. This pseudogene does not encode a functional protein and is not a known therapeutic or biological target. If therapeutic or biochemical relevance is desired, refer to the protein-coding GNPDA2 gene instead. Key note: The entry "glucosamine-6-phosphate deaminase 2 pseudogene" is NOT a valid molecular target for drug discovery or therapeutic intervention—it is a pseudogene. For functional, disease, or drug-related information, reference the protein-coding GNPDA2 gene[12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosamine-6-phosphate deaminase 2 pseudogene.